Botanic Healthcare Raises Rs 250 Crore in Equity Financing
Nutraceutical company Botanic Healthcare announced on Tuesday that it has successfully raised Rs 250 crore (approximately $30 million) in equity financing. This funding round was led by Stakeboat Capital, with additional participation from co-investors Abakkus Four2Eight Opportunities Fund and DS Group, which is one of Stakeboat Capital’s limited partners.
According to a statement from the company, this funding will allow Botanic Healthcare to:
- Consolidate its group entities
- Enhance its presence in the rapidly expanding global nutraceutical sector
Gaurav Soni, Founder and Director of Botanic Healthcare, stated, “With this funding, we will expand our product offerings, strengthen our global footprint, and invest in cutting-edge research to meet the evolving needs of our customers.”
Looking ahead, this fundraising initiative will support the company’s next phase of growth, including:
- Expanding into new markets
- Building strategic partnerships
Soni also mentioned that the company aims to achieve a fivefold increase in growth over the next three years. The strategic plans include:
- Enhancing its product portfolio
- Boosting research and development through joint ventures and strategic collaborations
In addition to investing in innovation, Botanic Healthcare is focusing on:
- Talent acquisition
- Strengthening its research and development pipeline
The company is recruiting top professionals in various fields, such as research, production, quality assurance, and sales to effectively scale its operations.
Chandrasekar Kandasamy, Managing Partner at Stakeboat Capital, remarked, “Their focus on innovation and clinically proven botanical extracts is poised to influence the future of health and wellness. This is their maiden private equity funding round, and we are excited to partner with Botanic Healthcare as they continue their mission of delivering exceptional quality and sustainable solutions globally.”
